×

Presentations


Acute Management of Hyperkalemia: What We Know & What We Need to Know AKI Management in the Developing World AKI: Past, Present and Future (Part I) AKI: Past, Present and Future (Part II) Anatomical and Functional Imaging of CAD in CKD Anemia in CKD. The 2019 KDIGO Standpoint. Anti-Glycemic Agents in 2019: Beyond Glucose Control

Presentations

Acute Management of Hyperkalemia: What We Know & What We Need to Know

AKI Management in the Developing World

AKI: Past, Present and Future (Part I)

AKI: Past, Present and Future (Part II)

Anatomical and Functional Imaging of CAD in CKD

Anemia in CKD. The 2019 KDIGO Standpoint.

Anti-Glycemic Agents in 2019:
Beyond Glucose Control

Aortic Aneurysms and Dissections – What is Special in CKD?

Appropriate Dialysis Access

Are we Listening? Patient Experiences and Symptoms as They Relate to Volume and Blood Pressure Management

Blood Pressure in CKD. The KDIGO 2019 Standpoint.

Blood Pressure Measurement, Targets, and Pharmacologic Management

Bone Fractures

CAD in CKD / ESKD — A Wolf in Sheep’s Clothing?

Can we predict the onset of ESRD?

Cardiac-Specific Biomarkers for Diagnosis & Prognosis in Patients with Kidney Disease: The Past, Present and Future

Cardiovascular and Chronic Kidney Disease

Care of transition period in Korean patients with CKD

CKD in Asia: What is Common and What is Different from the West?

CKD-Associated Pruritus

Controversies In Optimal Iron Use For CKD Anemia Management: Snapshot Of A 2019 KDIGO Conference

Controversies in the Treatment of ANCA-Associated Vasculitis

Cost Effectiveness of CKD-MBD Management in Japan

Cost-effectiveness of DAA Therapies: Examples Drawn from Asian Countries

Current Clinical Trials in Treating IgAN

Current Evidence & Future Perspectives in Non-Dietary Management of Chronic Hyperkalemia

Current Global & Regional Epidemiology of HCV Infection in Hemodialysis Units: Strategies for Preventing Transmission

Current therapies in diabetic kidney disease

Diabetes Management in Chronic Kidney Disease

Diagnosis and Management of HCV-related GN

Diagnostic tests and therapeutic targets for anemia of CKD

Dialysis Dosing: Kinetics Versus Physiology

Dialysis Initiation: Offering Real Choice and Adequate Preparation for Patients Facing Kidney Failure

Dietary Interventions for Potassium Management

Dietary Phosphate Intake Patterns in HD Patients: Understanding Determinants of Patient Behaviors

Epidemiology of Central & Peripheral Arterial Diseases in CKD

Epidemiology, Diagnosis, and Management of Renovascular Disease

Evidence Base for Management of Hypokalemia in ER, CKD, and Dialysis Patients

Fluid / Electrolyte Disturbances Associated with Cancer

Future Therapies for AKI – what’s likely to make it into the clinic?

Global & Regional Epidemiology of HCV: Pathways to Its Elimination by 2030

Global Burden of AKI

Global Burden of Dialysis Initiation

HCV-Positive ESKD Patient: Isolated Kidney versus Combined Kidney-Liver Transplantation?

Health Economics, Healthcare Payers, Guidelines and the Inherent Tension: can they ever agree?

Heart failure in chronic kidney disease

Heart Failure in Chronic Kidney Disease

Hemodynamic Consequences of Dialysis

HIF-PHI for Anemia in Patients with Kidney Disease Not Receiving Dialysis

HIV–associated nephropathy (HIVAN)

Home Therapies (Home HD & PD) Prescriptions as they Relate to Blood Pressure and Volume

Home-First Dialysis

How to Change Physician, Health System and Patient Behavior: the Knowledge to Action Cycle and Guideline Implementation

How to Merge and Compare Cohort Studies – CRIC & CKD-JAC

Hypoxia-inducible-factors in erythropoiesis, iron homeostasis and beyond

Identifying and Overcoming Barriers to Guideline Implementation

Impact of HCV on CKD Progression and Associated Comorbidities

Importance of Vascular Disease and What is New

In Vivo Responses of Phosphorus-based Food with Different Forms in Mice

Iron Deficiency Anemia: from the Cardiologist Perspective

Iron Deficiency Anemia: from the Nephrologist Perspective

Iron homeostasis regulation and role in health and disease

Iron therapy for managing anemia in CKD: formulations, dosing, benefits and cautions

KDIGO CKD-MBD Guideline Update

KDIGO Controversies Conference on Glomerular Diseases 2017: A summary

KDIGO Controversies Conference on Onco-Nephrology: What’s new for us?

KDIGO Guideline Update on Hepatitis C in CKD: New Evidence, New Recommendations

KDIGO Introduction

KDIGO Webinar on Nomenclature for Kidney Function & Disease: Implications for Researchers, Clinical Educators and Practitioners

KDIGO: Guias Mundiales de Práctica Clínica en Nefrología

KDIGO: What Is It and Why Is It Important?

Kidney Problems in Anti-Cancer Treatment

Kidney, Heart, and Vasculature Conference Series Overview

Lessons Acquired from HCV Outbreaks in Hemodialysis Units

Management and Treatment of Glomerular Diseases: Highlights of the New KDIGO 2020 Guideline

Management of CKD and AKI in Malignancy

Management of Hyperkalaemia

Managing Acute & Chronic Hyperkalemia: Solving the Puzzle

Membranous Nephropathy

Models of Care

Multidisciplinary Care for AKI

New and emerging therapies for anemia of CKD

Non-Embolic and Embolic Mechanisms of Stroke

Novel Treatments for Solid-Organ & Hematologic Malignancies

Nutritional Management in CKD-MBD

Onco-Nephrology: Perspectives from Nephrology and Oncology

Opportunities to Harness Technology to Improve Blood Pressure and Volume Management in Maintenance Dialysis

Overview of the 2017 KDIGO CKD-MBD Guideline: A Focus on SHPT & Hyperphosphatemia

PAD from a Renal Perspective

Pathogenesis & Prognosis of ANCA Vasculitis

Pathophysiology of Vascular Calcification

Patient and Caregiver Perspectives on the Definitions and Impact of Terms Used to Describe Kidney Health

Patient Perspective and Symptom Control in Dialysis Initiation

Perspectives from an AKI Survivor

Pharmacologic treatment of chronic hyperkalemia in CKD

Physiology of K Homeostasis

Population Screening

Potassium Controversies

Potassium Management

Potassium Management: Observations from a KDIGO Controversies Conference

Precision Medicine:
Towards a Mechanistic Definition of Kidney Disease

Preventing AKI in Cardiac Surgery

Recent Approach of KDIGO to CKD-CVD

Renal Involvement in Hematological Disorders

Reno-Protective Effect of SGLT2 Inhibitors

Screening, Diagnosis, and Assessment of Liver Disease in CKD Patients with HCV

System Perspectives & Health Economics

Testing, Incidence and Outcomes of Cardiac Disease in Kidney Transplant Candidates

The AMA Manual of Style Perspective

The Crisis of AKI Follow-Up

The In-Center Hemodialysis Prescription as it Relates to Blood Pressure and Volume

The KDIGO AKI Guidelines: from 2011-2019

The KDIGO Diabetes Guidelines – Implications for the practicing nephrologist

The Patient Perspective

The Perceived vs Real Importance of Hyperkalemia in CV Practice

Towards the Implementation of the 2018 KDIGO Guideline on Hepatitis C in CKD

Treatment Challenges in Special Populations

Treatment of HCV in Kidney Transplant Recipients

Treatment Strategies for Chronic HCV in CKD G4 and G5 Including Dialysis (HD and PD)

Update on randomized clinical trials in anemia of CKD

Valvular Disease in CKD / ESKD

What do we know about available kidney measures and their value for detecting CKD and discriminating Stage and Prognosis?

What’s new in the 2017 KDIGO CKD MBD Guideline?

When to Treat HCV – Before or After a Kidney Transplant?